ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer.

Hossein Borghaei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.